Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04736550 · ClinicalTrials.gov registry record · NA
Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Opioid Use Disorders ("EXPO" Pilot Trial)
A NA study of Pain and Opioid Use Disorder, sponsored by Case Western Reserve University.
- Active
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 2
- Study locations
NCT04736550: Active NA study of Pain and Opioid Use Disorder, sponsored by Case Western Reserve University.
NCT04736550 is a NA study of Pain and Opioid Use Disorder that is active but no longer recruiting, run by Case Western Reserve University. The registered enrollment target is 63 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04736550, a NA study of Pain and Opioid Use Disorder, is active but no longer recruiting, sponsored by Case Western Reserve University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this pilot trial is to determine the feasibility of integrating exercise and psychotherapy that is specifically targeted to reducing and managing pain into residential drug treatment programs. The investigators will evaluate the feasibility (adherence) of integrating 'assisted' rate cycling, voluntary rate cycling and psychotherapy for pain (I-STOP) in participants with an opioid use disorder (OUD) and pain enrolled in residential drug treatment programs. The investigators will also explore the potential effects of 'assisted' rate cycling, voluntary rate cycling and I-STOP on pain, cravings, depression, anxiety, weight and sleep.
Primary Outcome
Percentage of exercise and psychotherapy sessions attended
Conditions Studied
Interventions
- BEHAVIORAL Exercise
- BEHAVIORAL Psychotherapy for Pain (I-STOP)
Study Locations (2)
Colorado
- University of Colorado at Denver - Denver
Ohio
- Case Western Reserve University - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2021-01-08 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT04736550 still lists
NCT04736550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.
NCT04736550 reports a single indexed study location in Colorado, Ohio.
Frequently Asked Questions
What is clinical trial NCT04736550 about?
NCT04736550 is a clinical study titled "Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Opioid Use Disorders ("EXPO" Pilot Trial)". The purpose of this pilot trial is to determine the feasibility of integrating exercise and psychotherapy that is specifically targeted to reducing and managing pain into residential drug treatment programs. The investigators will evaluate the feasibility (adherence) of integrating 'assisted' rate c...
What is the current status of trial NCT04736550?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 63 participants. The study started on 2021-01-08. Estimated completion is 2025-12-31.
What conditions does trial NCT04736550 study?
This clinical trial studies the following conditions: Pain, Opioid Use Disorder.
What interventions are being tested in trial NCT04736550?
The interventions under investigation include: Exercise (BEHAVIORAL), Psychotherapy for Pain (I-STOP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04736550?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04736550 being conducted?
This trial has 2 study locations across Colorado, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04736550's enrollment target sits among peer trials
63 222nd of 374 higher than 153 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI